Norflex (Orphenadrine Citrate)

Orphenadrine citrate works by blocking muscarinic receptors in the central nervous system, which reduces the reflex pathways that cause muscle contraction. This central anticholinergic action lowers muscle tone and eases spasm, while its mild antihistaminic effect may also contribute to symptom relief.

The appropriate dose of Norflex is determined by the prescribing healthcare professional based on the individual’s condition, age, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Safety data for Norflex in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should only be used if the potential benefit outweighs any possible risk to the fetus or infant, and under close medical supervision.

To order Norflex, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets, and will request trade or institutional credentials before providing pricing, availability, shipping details and import documentation.

Norflex belongs to the anticholinergic muscle relaxant class, whereas a common alternative such as cyclobenzaprine is a centrally acting skeletal muscle relaxant with a different receptor profile. Both relieve spasm, but Norflex may cause more anticholinergic side effects, while cyclobenzaprine is associated with greater sedation.

Norflex tablets should be stored at ambient temperature below 25 °C, in the original packaging, protected from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged or the tablets appear discolored.

Norflex is taken orally, usually with a glass of water. It can be taken with or without food, but patients should follow the specific instructions given by their prescriber regarding timing and any dietary considerations.

Serious risks include tachycardia, urinary retention, and severe allergic reactions such as rash or angioedema. Patients should seek immediate medical attention if they experience rapid heart rate, difficulty urinating, or signs of an allergic response.

Norflex should be avoided in patients with known hypersensitivity to orphenadrine or any excipients, those with narrow‑angle glaucoma, severe hepatic impairment, or uncontrolled cardiac arrhythmias. Caution is also advised for elderly individuals due to an increased risk of sedation and falls.